Predicting coronary risk in the general population--is it necessary to measure high-density lipoprotein cholesterol?

J Cardiovasc Risk. 2003 Apr;10(2):137-41. doi: 10.1097/01.hjr.0000060844.48106.ff.

Abstract

Background: The Joint British Societies Coronary Risk Prediction Charts recommend the use of a high-density lipoprotein cholesterol value of 1 mmol/l where actual values have not been measured. It is important to quantify the impact of this advice if risk assessments are to be sufficiently accurate to guide treatment decisions.

Design: The risks of 5005 individuals from the Health Survey for England 1998 were calculated using the Joint British Societies charts. Each individual's risk was recalculated assuming a high-density lipoprotein cholesterol value of 1 mmol/l. These risk estimates were compared with those derived from the Framingham equation.

Methods: Using the Framingham equation as the gold standard, the positive and negative predictive values, sensitivity and specificity with 95% confidence intervals of the Joint British charts with actual and estimated high-density lipoprotein cholesterol values were calculated.

Results: At the 30% 10-year coronary heart disease risk threshold using measured high-density lipoprotein cholesterol values, the charts had a sensitivity of 83% and specificity of 99%. Using an estimated high-density lipoprotein cholesterol value of 1 mmol/l reduced the sensitivity to 58% with a specificity of 98%.

Conclusions: In the presence of measured high-density lipoprotein cholesterol values there was good agreement between the Framingham equation and the Joint British Societies charts. The use of a fixed high-density lipoprotein cholesterol value of 1 mmol/l introduced important and significant errors into the risk assessment. This study reinforces the need to measure both total and high-density lipoprotein cholesterol when assessing coronary risk.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers / blood
  • Cholesterol, HDL / blood*
  • Coronary Disease / blood
  • Coronary Disease / etiology*
  • Female
  • Health Surveys
  • Humans
  • Male
  • Middle Aged
  • Predictive Value of Tests
  • Risk Assessment / methods*
  • Risk Factors
  • Sensitivity and Specificity
  • Sex Factors
  • Time Factors
  • United Kingdom

Substances

  • Biomarkers
  • Cholesterol, HDL